Jason Cavalier

Jason Cavalier is a declared insider of Lyra Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 16 October 2024 to 1 April 2026, the count stands at 5 filings.

Sales make up the whole of the open-market record (2 sales, €7,416). Besides market trades, the filings include 2 share grants. 2026 to date brings no purchases and 1 sale.

The record was last updated on 3 April 2026 with a transaction in Lyra Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.